CapsoVision

CapsoVision EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CapsoVision (CV) as of Oct 18, 2026 is -25.52 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -19.92 M USD — a change of 28.11% (lower).

EBITDA

-25.52 MUSD

YoY

28.11%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CapsoVision is 2025 -25.52 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CapsoVision was 2024 -19.92 M USD. It decreases by 28.11% lower compared to the previous year.

The CapsoVision EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2023
-11.35 M USD
Jan 1, 2024
-19.92 M USD
Jan 1, 2025
-25.52 M USD
The CapsoVision EBITDA history
YEAREBITDAYoY
-25.52 MUSD+28.11%
-19.92 MUSD+75.53%
-11.35 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CapsoVision Stock analysis

What does CapsoVision do? CapsoVision Inc is a health care company based in Saratoga, California, operating within the health care sector. The company has 99 employees and is scheduled to go public with an IPO on July 2, 2025. CapsoVision develops medical technology products, including a small bowel capsule endoscope called CapsoCam Plus. This device utilizes a 360 panoramic lateral view to provide more comprehensive imaging compared to traditional end-facing cameras. The product is designed to be wire-free, enhancing patient comfort and convenience. The company also offers CapsoCloud, a cloud-based software application for secure and convenient clinical data management. Additionally, CapsoVision provides a capsule collection kit, a single-use, sanitary kit for patients to collect, store, and transport the CapsoCam Plus capsule. The company's website is https://www.capsovision.com/. CapsoVision Inc is focused on advancing medical technology solutions for gastrointestinal diagnostics, with a particular emphasis on improving patient experience through innovative design and secure data handling. CapsoVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CapsoVision stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CapsoVision is -25.52 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CapsoVision changed from -19.92 M USD to -25.52 M USD, representing a 28.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) CapsoVision since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CapsoVision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CapsoVision

All Key Metrics — CapsoVision